We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AMBELVIST Bayer Australia Ltd
Product name
AMBELVIST
Sponsor
Accepted date
Sep-2025
Active ingredients
gadoquatrane
Summary of proposed indication
Ambelvist (gadoquatrane) is for diagnostic use only. It is proposed as a contrast agent to be used during MRI (magnetic resonance imaging) scans. It improves the clarity of MRI images, allowing for better detection of known or suspected pathology in the central nervous system (CNS) and body, in adult and paediatric patients of all ages.
Application type
A (new medicine)
Publication date
Sep-2025